osimertinib
astrazeneca
['lung']
new partners for egfr-mutant lung cancer: is there a role for neoadjuvant osi? how can we enhance osi activity? ways to overcome osi resistance? #asco23 
MRCP(UK) •KBIM •Former Fellow @OttawaHospital •Thoracic and Sarcoma Medical Oncologist • Madridista 14/35 اختصاصي أول بالأمراض الباطنية وطب الأورام وأورام الرئة